Top five unique options volume: AMAT EFX NKE AXON GE
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Axovant Sciences (AXON) PT Lowered to $9 at Evercore ISI
September 26, 2017 12:07 PM EDTEvercore ISI analyst Josh Schimmer lowered his price target on Axovant Sciences (NASDAQ: AXON) to $9.00 (from $30.00) while maintaining an Outperform rating after MINDSET Trial Fails
... MoreAxovant Sciences (AXON) PT Lowered to $25 at Cowen; Lewy Body Program Remains Focus
September 26, 2017 11:48 AM EDTCowen analyst Ritu Baral lowered his price target on Axovant Sciences (NASDAQ: AXON) to $25.00 (from $30.00) while maintaining an Outperform rating after the company reported the pivotal Ph3 MINDSET trial of intepirdine in Alzheimer's failed to meet its primary endpoint.
Baral notes... More
UPDATE: Piper Jaffray Downgrades Axovant Sciences (AXON) to Neutral
September 26, 2017 10:53 AM EDT(Updated - September 26, 2017 11:02 AM EDT)
(updated to add analyst comment)
Piper Jaffray downgraded Axovant Sciences (NASDAQ: AXON) from Overweight to Neutral with a price target of $9.00 (from $32.00).
Analyst Charles Duncan says the pipeline needs to be rebuild... More
Oppenheimer Downgrades Axovant Sciences (AXON) to Perform
September 26, 2017 10:48 AM EDTOppenheimer downgraded Axovant Sciences (NASDAQ: AXON) from Outperform to Perform.
For an analyst ratings summary and ratings history on Axovant Sciences click here. For more ratings news on Axovant Sciences click here.
Shares of Axovant Sciences closed at $24.25 yesterday.
... More